116 related articles for article (PubMed ID: 29066691)
61. [Effects of Preoperative Immune and Nutritional Indices on the Prognosis of pStage Ⅱ and Ⅲ Colorectal Cancer].
Nakata Y; Furuya S; Takiguchi K; Ashizawa N; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Sudo M; Kawaida H; Inoue S; Kono H; Ichikawa D
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2389-2391. PubMed ID: 32156941
[TBL] [Abstract][Full Text] [Related]
62. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
[TBL] [Abstract][Full Text] [Related]
63. [Assessment of host status in patients treated with mFOLFOX6 adjuvant chemotherapy after colorectal cancer surgery].
Sagawa M; Yoshimatsu K; Yokomizo H; Osawa G; Matsumoto A; Yano Y; Nakayama M; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1587-9. PubMed ID: 24393857
[TBL] [Abstract][Full Text] [Related]
64. Extranodal extension status is a powerful prognostic factor in stage III colorectal cancer.
Kim CW; Kim J; Yeom SS; Lee JL; Yoon YS; Park IJ; Lim SB; Baek S; Yu CS; Kim JC
Oncotarget; 2017 Sep; 8(37):61393-61403. PubMed ID: 28977872
[TBL] [Abstract][Full Text] [Related]
65. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
[TBL] [Abstract][Full Text] [Related]
66. Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma.
Yoshimura T; Suzuki H; Takayama H; Higashi S; Hirano Y; Tezuka M; Ishida T; Ishihata K; Amitani M; Amitani H; Nishi Y; Nakamura Y; Imamura Y; Nozoe E; Inui A; Nakamura N
Front Pharmacol; 2022; 13():996757. PubMed ID: 36479205
[No Abstract] [Full Text] [Related]
67. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
[TBL] [Abstract][Full Text] [Related]
68. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
69. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
[TBL] [Abstract][Full Text] [Related]
70. [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].
Liang J; Wei Y; Zhao C; Hong C
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1663-6. PubMed ID: 23174600
[TBL] [Abstract][Full Text] [Related]
71. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
72. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
[TBL] [Abstract][Full Text] [Related]
73. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
74. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.
Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038
[TBL] [Abstract][Full Text] [Related]
75. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
[TBL] [Abstract][Full Text] [Related]
76. Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study.
Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ohgi K; Otsuka S; Notsu A; Uesaka K
World J Surg; 2022 Jan; 46(1):246-258. PubMed ID: 34661701
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
78. [Association of NLRC3 with prognosis and tumor immunity in patients with stage III colorectal cancer].
Wang D; Pei Q; Tan F; Zhou Y; Wang K; Pei H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):535-543. PubMed ID: 31303617
[TBL] [Abstract][Full Text] [Related]
79. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
80. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
